These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33497749)

  • 1. Provider Attitudes and Practices Regarding Intrauterine System (IUS) Insertion in Adolescents With and Without Bleeding Disorders for Management of Heavy Menstrual Bleeding.
    O'Flynn O'Brien KL; Wheeler AP; Borzutzky C; Haley KM; Kouides P; Adeyemi-Fowode O
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):514-521. PubMed ID: 33497749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Jordan V
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD002126. PubMed ID: 32529637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.
    Khalighi M; Wheeler AP; Adeyemi-Fowode OA; Kouides PA; Durazo-Arvizu RA; Haley K; Dersch CM; Weyand AC; Baldwin MK; Borzutzky C
    J Adolesc Health; 2022 Aug; 71(2):204-209. PubMed ID: 35430143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
    Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
    Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Predicting Removals of the Levonorgestrel-Releasing Intrauterine System in an Adolescent Cohort.
    Baum A; Chan K; Sachedina A; Grover SR
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):171-176. PubMed ID: 38128876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.
    Kaunitz AM; Inki P
    Drugs; 2012 Jan; 72(2):193-215. PubMed ID: 22268392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
    Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
    Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
    Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
    Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome.
    Huguelet PS; Laurin JL; Thornhill D; Moyer G
    J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):147-152.e1. PubMed ID: 34775059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care.
    Kai J; Middleton L; Daniels J; Pattison H; Tryposkiadis K; Gupta J;
    Br J Gen Pract; 2016 Dec; 66(653):e861-e870. PubMed ID: 27884916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
    Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.
    Kaunitz AM; Bissonnette F; Monteiro I; Lukkari-Lax E; DeSanctis Y; Jensen J
    Contraception; 2012 Nov; 86(5):452-7. PubMed ID: 22959906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders.
    Rimmer E; Jamieson MA; James P
    Haemophilia; 2013 Nov; 19(6):933-8. PubMed ID: 23711358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire survey.
    Ben-Haroush A; Oron G; Yogev Y; Yeshaya A; Kaplan B
    Eur J Contracept Reprod Health Care; 2004 Mar; 9(1):29-33. PubMed ID: 15352692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel-releasing intrauterine system versus conventional medical therapy for heavy menstrual bleeding in the Asia-Pacific region.
    Lee BS; Ling X; Asif S; Kraemer P; Hanisch JU; Inki P
    Int J Gynaecol Obstet; 2013 Apr; 121(1):24-30. PubMed ID: 23340271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
    Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
    Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
    BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.